基本信息 产品详情 公司简介 推荐产品
网站主页 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine hydrochloride 化合物 CCT128930 hydrochloride
  • 化合物 CCT128930 hydrochloride|T6303L|TargetMol

化合物 CCT128930 hydrochloride|T6303L|TargetMol

CCT128930 hydrochloride
2453324-32-6
439 1mg 起订
579 2mg 起订
790 5mg 起订
上海 更新日期:2025-11-17

TargetMol中国(陶术生物)

VIP4年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 CCT128930 hydrochloride
英文名称:
CCT128930 hydrochloride
CAS号:
2453324-32-6
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T6303L

Product Introduction

Bioactivity

名称CCT128930 hydrochloride
描述CCT128930 hydrochloride (CCT128930 hydrochloride) is a potent and selective inhibitor of AKT with IC50 of 6 nM. CCT128930 hydrochloride induces cell cycle arrest, DNA damage, and autophagy. CCT128930 hydrochloride has 28-fold selectivity over the closely related PKA kinase (IC50: 168 nM) through the targeting of Met282 of AKT, as well as 20-fold selectivity over p70S6K (IC50: 120 nM).
体外活性In U87MG human glioblastoma cells, CCT128930 hydrochloride(0.1-60 μM; 1 hour) shows an initial induction of AKT phosphorylation at serine 473 up to 20 μM, followed by a decreased in phosphorylation at higher concentrations[1]. CCT128930 (18.9 μM) hydrochloride causes an increase in phosphorylation of pSer473 AKT after 30 minutes, which is sustained for 48 hours. Total AKT protein signal decreases gradually from 8 hours to 48 hours of treatment[1]. The GI50 values of CCT128930 hydrochloride for growth inhibition are 6.3 μM for U87MG human glioblastoma cells, 0.35 μM for LNCaP human prostate cancer cells, and 1.9 μM for PC3 human prostate cancer cells, all of which are PTEN-deficient human tumor cell lines[1]. CCT128930 hydrochloride inhibits direct substrates of AKT (Ser9 GSK3β, pThr246 PRAS40 and pT24 FOXO1/p32 FOXO3a) at ≥5 μM, and the downstream target, pSer235/236 S6RP at ≥10 μM, with generally constant levels of the respective total proteins and GAPDH[1].
体内活性CCT128930 hydrochloride shows antitumor activities in U87MG and BT474 human breast cancer xenografts[1].
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度DMSO : 55 mg/mL (145.39 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.29 mM), Sonication is recommended.
关键字U87MG | selective | PTEN | Protein kinase B | PKB | PKA | phosphorylation | p70S6K | Inhibitor | inhibit | growth | glioblastoma | DNA damage | cycle | cell | CCT-128930 hydrochloride | CCT-128930 Hydrochloride | CCT128930 Hydrochloride | CCT128930 hydrochloride | CCT-128930 | CCT128930 | CCT 128930 Hydrochloride | CCT 128930 | BT474 | breast cancer | Autophagy | arrest | Apoptosis | Akt2 | Akt
相关产品Urea | Naringin | Guanidine hydrochloride | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Metronidazole | Dextran sulfate sodium salt (MW 5000) | Hydroxychloroquine | Stavudine | Paeonol | Ethyl linoleate
相关库抑制剂库 | 抗乳腺癌化合物库 | 抗癌活性化合物库 | 经典已知活性库 | 已知活性化合物库 | 激酶抑制剂库 | 细胞凋亡化合物库 | 抗衰老化合物库 | 免疫/炎症分子化合物库 | 膜蛋白靶向化合物库 | 酪氨酸激酶分子库 | 神经元分化化合物库
CCT128930 hydrochloride(885499-61-6 Free base)|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 CCT128930 hydrochloride相关厂家报价

  • CCT128930
  • CCT128930
  • 陕西缔都新材料有限公司 VIP
  • 2025-09-17
  • 询价
内容声明
拨打电话 立即询价